(MENAFN- GlobeNewsWire - Nasdaq) Driven by surging demand for precision and efficiency, laboratory robotics is transforming scientific research and healthcare. Powered by AI, modular designs, and collaborative robots, this dynamic market unlocks new frontiers in drug discovery, diagnostics, and personalized medicine.

New Delhi, Dec. 02, 2024 (GLOBE NEWSWIRE) -- The global laboratory robotics market is projected to attain a value of US$ 564.2 million by 2032 from US$ 309.5 million in 2023 at a CAGR of 6.9% during the forecast period 2024–2032.

The laboratory robotics market is experiencing a significant upsurge, fueled by the increasing demand for efficiency and precision in scientific research. A critical driver is the complexity of modern laboratory procedures, especially in genomics and pharmaceuticals. It is estimated that over 500 genomic sequencing facilities worldwide have integrated robotic systems to manage high-throughput sequencing tasks, effectively doubling or even tripling their output compared to manual operations. Additionally, the urgency to accelerate drug discovery processes has led to the adoption of laboratory robots in over 1,000 pharmaceutical R&D centers globally, enabling the screening of millions of compounds annually and reducing lead times by as much as six months. Research institutes have also reported a significant rise in their ability to process up to 5,000 unique samples per day with robotic automation, compared to fewer than 500 samples using manual processes.

Request Sample Report @

Emerging trends in the laboratory robotics market emphasize the integration of advanced technologies such as artificial intelligence (AI) and machine learning (ML) with robotics. In recent years, over 300 newly developed laboratory robotic platforms have incorporated AI capabilities, facilitating autonomous decision-making and real-time error correction. For instance, AI-enabled robots in clinical diagnostics laboratories have processed over 10 million diagnostic samples globally in 2023 alone, achieving significant reductions in sample processing times, sometimes by as much as half. Moreover, the development of collaborative robots, or 'cobots,' has gained significant traction, with over 25,000 cobots deployed in laboratory settings worldwide in the past year. These cobots work alongside human technicians, enhancing safety and productivity by handling hazardous materials or performing repetitive tasks. In one study, cobots successfully reduced human exposure to harmful chemicals in over 15,000 experiments conducted across labs in North America and Europe.

Opportunity and Future Outlook of Laboratory Robotics Market

Opportunities in the market are abundant, particularly in the customization and scalability of laboratory robotics solutions. Small and medium-sized laboratories are increasingly seeking modular robotic systems that can be tailored to specific applications. To cater to this demand, over 100 new modular robotic systems were launched in 2023, supporting applications ranging from liquid handling to analytical measurements. Investment in this sector has also been robust, with venture capitalists funding over 200 startups globally, focusing on innovative laboratory automation solutions. For example, startups specializing in robotic lab assistants have collectively secured funding rounds totaling more than $1 billion in 2023 alone. Additionally, government initiatives in regions such as North America, Europe, and Asia allocated over $500 million in grants and subsidies in the same year to promote the adoption of advanced laboratory technologies, with some programs offering full financial coverage for initial setup costs.

The outlook for the laboratory robotics market is highly promising. As the demand for rapid, accurate, and reproducible results intensifies, robotics will become increasingly indispensable in laboratory environments. The integration of robotics with cutting-edge technologies such as nanotechnology and biotechnology is set to unlock new potentials. For example, over 50 laboratories worldwide are currently piloting robots capable of manipulating nano-scale materials, a technology expected to revolutionize materials science research. Efforts to overcome current challenges, such as high initial costs and technical complexities, are evident through collaborative initiatives between industry leaders and research institutions, with over 200 partnerships announced in 2023. With continuous innovation and investment, the laboratory robotics market is poised for transformative growth, promising unprecedented advancements in scientific discovery and healthcare outcomes.

Key Findings in Laboratory Robotics Market

Market Forecast (2032)	US$ 564.2 million
CAGR	6.9%
Largest Region (2023)	North America (38.9%)
By Type	Biological Laboratory Robotics (34.5%)
By Application	Drug Discovery (38.2%)
By End Users	Biotechnology And Pharmaceutical Companies (30%)
Top Drivers	Increasing demand for high-throughput screening accelerates laboratory robotics adoption in drug discovery. Need for enhanced precision and reduction of human error prompts robotics implementation. Growing investment in research and development boosts automation in laboratories globally.
Top Trends	Integration of artificial intelligence and machine learning revolutionizes laboratory robotics systems in 2023. Development of compact, miniaturized robotic systems for microfluidic applications is a key trend. Adoption of cloud platforms for remote monitoring and control of laboratory robots rises.
Top Challenges	High initial investment costs significantly hinder adoption of laboratory robotics technologies globally. Technical complexities necessitate specialized personnel to operate advanced laboratory robotic systems. Cybersecurity concerns regarding data integrity and protection hinder laboratory robotics adoption.

Biological Laboratory Robots Dominate Market Driven by Genomics and Biotech Advancements

As of 2023, biological laboratory robots have established a commanding lead in the global laboratory robotics market, primarily due to the explosive growth in genomics and biotechnology applications. This dominance is fueled by the need for automation in handling complex biological experiments and large data sets. With over 20,000 genomics labs worldwide more likely to adopt robotic systems in the years to come, there's a significant push towards high-throughput sequencing and analysis. The rise of personalized medicine, an industry projected to reach $2.5 trillion in value, has increased demand for robots that can process massive amounts of genetic data efficiently.

Key end users driving the demand for biological laboratory robots are pharmaceutical companies, biotechnology firms, clinical research organizations (CROs), and academic institutions. Pharmaceutical companies in the laboratory robotics market, investing around $220 billion annually in R&D, utilize robots to enhance drug discovery and streamline workflows. Biotechnology firms, numbering over 7,500 globally, depend on robots for gene editing technologies like CRISPR, which is a market expected to reach $10 billion. CROs, responsible for conducting over 80% of clinical trials worldwide, employ robots to improve efficiency and data integrity. Academic institutions, backed by research grants totaling $90 billion, integrate robots into their laboratories to advance scientific research and education. The demand from these end users reinforces the dominance of biological laboratory robots, as they seek solutions to improve accuracy, scalability, and throughput in their operations.

Laboratory Robots Revolutionize Drug Discovery Amidst Rising $100 Billion Pharma R&D Spending

In 2023, laboratory robotics market is at the forefront of revolutionizing drug discovery processes, addressing the challenges faced by pharmaceutical companies that collectively invest over $100 billion annually in R&D. The average time to develop a new drug is 12 years, with costs exceeding $2.6 billion per drug. Laboratory robots enhance efficiency by automating high-throughput screening, enabling the testing of up to 100,000 compounds per day, significantly accelerating the early stages of drug discovery. They play a crucial role in sample preparation, compound management, and data analysis, which are essential for identifying potential drug candidates from vast chemical libraries containing over 10 million compounds.

End users benefit from increased productivity, reduced costs, and improved accuracy. Robots minimize human error, leading to a high success rate in preclinical trials, and potentially saving companies up to $150 million per failed drug avoided. The integration of AI-powered robots allows for predictive modeling, improving decision-making in lead optimization. Globally, pharma companies spend approximately $50 billion on drug discovery annually, and robots help in reducing this expenditure by streamlining workflows. Laboratory robots also contribute to compliance with regulatory standards by ensuring data integrity and traceability, which is critical given that regulatory delays can cost companies up to $1 million per day.

Biotech and Pharma Firms Lead Laboratory Robotics Adoption for Enhanced Efficiency

Biotechnology and pharmaceutical companies in the laboratory robotics market are the largest end users of laboratory robots worldwide in 2023, leading the market due to their substantial R&D activities and the necessity for high-throughput, precise laboratory processes. The pharmaceutical industry alone has over 7,000 active compounds in development, necessitating automation to handle the extensive testing and data analysis required. Biotech firms, numbering more than 6,500 globally, utilize laboratory robots for applications like gene sequencing and cell manipulation, areas experiencing significant growth with the genomics market valued at $35 billion. These companies command a market share estimated at $3 billion in laboratory robotics, highlighting their dominance.

Key factors compelling these companies in the laboratory robotics market to adopt laboratory robots include the need to accelerate research timelines, reduce operational costs, and maintain compliance with stringent regulatory standards. Laboratory robots can operate continuously, increasing productivity by processing up to 1,000 samples per hour. They also enhance precision, with error rates dropping significantly, leading to cost savings of up to $100 million over a product's development lifecycle. From a macroeconomic perspective, the global demand for new and effective therapeutics drives companies to adopt technologies that expedite development. The pharmaceutical market is projected to reach $1.5 trillion in value, emphasizing the scale at which these companies operate.

Request Free Customization of this report:

Top 4 Players Control Over 57% Market Share: Siemens Healthineers' Dominance in the Laboratory robotics Market to Remain Unchallenged

Siemens Healthineers has established itself as a dominant player in the laboratory robots industry, primarily due to its significant market share and strategic positioning. As of 2024, Siemens Healthineers held a 13.54% share of the AI in medical diagnostics market and more than 30% in laboratory robotics market, leading the sector and surpassing competitors like Merative L.P. This leadership is supported by the company's comprehensive approach to healthcare solutions, which spans from prevention and early detection to diagnosis, treatment, and aftercare, offering a full range of patient care products and solutions. The company's global presence, with operations in over 130 countries and a workforce of approximately 49,000 employees, further solidifies its market position.

The company's financial performance underscores its market dominance. Siemens Healthineers achieved an estimated annual revenue of €15 billion, reflecting its strong foothold in segments such as medical imaging, where it holds a significant market share of around 23.5%. This financial strength is complemented by strategic investments in research and development, with a focus on integrating artificial intelligence to enhance diagnostic accuracy and patient outcomes. The company's commitment to innovation is evident in its advancements in MRI, CT scans, and X-ray technology, which are crucial for maintaining its competitive edge.

Siemens Healthineers' strategic initiatives in the laboratory robotics market have been pivotal in maintaining its leadership. The company actively seeks out healthcare segments where competitors like Medtronic and Johnson & Johnson have less dominance, establishing strongholds in these areas. Additionally, Siemens Healthineers is expanding its global market share by tapping into underserved geographical markets with burgeoning healthcare sectors. Forming strategic alliances and acquiring companies that complement or enhance its capabilities are also key strategies that ensure Siemens Healthineers' continued relevance and leadership in the dynamic healthcare market.

Global Laboratory Robotics Market Major Players:

• AB Controls
• Aerotech
• Anton Paar
• Aurora Biomed
• Biosera
• Chemspeed Technologies
• Cleveland Automation Engineering
• Hamilton Robotics
• HighRes Biosolutions
• Hudson Robotics
• Labman
• PerkinElmer Inc.
• Protedyne (LabCorp)
• Siemens AG
• ST Robotics
• Tecan Group
• Thermo Fisher Scientific
• Universal Robots
• Yaskawa Electric
• Other Prominent Players

Market Segmentation:

By Type:

• Low-Cost Laboratory Robotics
• Biological Laboratory Robotics
• Pharmaceutical Laboratory Robotics
• Molecular Laboratory
• Others

By Application:

• Drug Discovery
• Clinical Diagnosis
• Microbiology Solutions
• Genomics Solutions
• Proteomics Solutions

By End User:

• Clinical Laboratories
• Research Laboratories
• Biotechnology and Pharmaceutical companies
• Hospitals and Diagnostic Laboratories
• Research and Academic Institutes
• Forensic Laboratories
• Environmental Testing Laboratories
• Food and Beverage Industry

By Region:

• North America
• Europe
• Asia Pacific
• Middle East & Africa
• South America

View report summary and Table of Contents (TOC):

About Astute Analytica

Astute Analytica is a global analytics and advisory company which has built a solid reputation in a short period, thanks to the tangible outcomes we have delivered to our clients. We pride ourselves in generating unparalleled, in depth and uncannily accurate estimates and projections for our very demanding clients spread across different verticals. We have a long list of satisfied and repeat clients from a wide spectrum including technology, healthcare, chemicals, semiconductors, FMCG, and many more. These happy customers come to us from all across the Globe. They are able to make well calibrated decisions and leverage highly lucrative opportunities while surmounting the fierce challenges all because we analyze for them the complex business environment, segment wise existing and emerging possibilities, technology formations, growth estimates, and even the strategic choices available. In short, a complete package. All this is possible because we have a highly qualified, competent, and experienced team of professionals comprising of business analysts, economists, consultants, and technology experts. In our list of priorities, you-our patron-come at the top. You can be sure of best cost-effective, value-added package from us, should you decide to engage with us.

Contact Us:
Astute Analytica
Phone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World)
For Sales Enquiries: ...
Website:
LinkedIn | Twitter | YouTube

CONTACT: Contact Us: Astute Analytica Phone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World) For Sales Enquiries: ... Website:

MENAFN02122024004107003653ID1108946927